|
|
Blood, 15 November 2004, Vol. 104, No. 10, pp. 3097-3105.
Prepublished online as a Blood First Edition Paper on July 13, 2004; DOI 10.1182/blood-2004-03-1224.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development
Brandon K. Hadland,
Stacey S. Huppert,
Jyotshnabala Kanungo,
Yingzi Xue,
Rulang Jiang,
Thomas Gridley,
Ronald A. Conlon,
Alec M. Cheng,
Raphael Kopan, and
Gregory D. Longmore
From the Departments of Medicine and Cell Biology, Molecular Biology and Pharmacology, and Medicine and Immunology, Washington University School of Medicine, St Louis, MO; The Jackson Laboratory, Bar Harbor, ME; the Department of Genetics, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH.
Notch1 is known to play a critical role in regulating fates in numerous cell types, including those of the hematopoietic lineage. Multiple defects exhibited by Notch1-deficient embryos confound the determination of Notch1 function in early hematopoietic development in vivo. To overcome this limitation, we examined the developmental potential of Notch1/ embryonic stem (ES) cells by in vitro differentiation and by in vivo chimera analysis. Notch1 was found to affect primitive erythropoiesis differentially during ES cell differentiation and in vivo, and this result reflected an important difference in the regulation of Notch1 expression during ES cell differentiation relative to the developing mouse embryo. Notch1 was dispensable for the onset of definitive hematopoiesis both in vitro and in vivo in that Notch1/ definitive progenitors could be detected in differentiating ES cells as well as in the yolk sac and early fetal liver of chimeric mice. Despite the fact that Notch1/ cells can give rise to multiple types of definitive progenitors in early development, Notch1/ cells failed to contribute to long-term definitive hematopoiesis past the early fetal liver stage in the context of a wild-type environment in chimeric mice. Thus, Notch1 is required, in a cell-autonomous manner, for the establishment of long-term, definitive hematopoietic stem cells (HSCs).

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M.-J. Yoon, B.-K. Koo, R. Song, H.-W. Jeong, J. Shin, Y.-W. Kim, Y.-Y. Kong, and P.-G. Suh
Mind bomb-1 Is Essential for Intraembryonic Hematopoiesis in the Aortic Endothelium and the Subaortic Patches
Mol. Cell. Biol.,
August 1, 2008;
28(15):
4794 - 4804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stahl, K. Uemura, C. Ge, S. Shi, Y. Tashima, and P. Stanley
Roles of Pofut1 and O-Fucose in Mammalian Notch Signaling
J. Biol. Chem.,
May 16, 2008;
283(20):
13638 - 13651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ghiaur, M. J. Ferkowicz, M. D. Milsom, J. Bailey, D. Witte, J. A. Cancelas, M. C. Yoder, and D. A. Williams
Rac1 is essential for intraembryonic hematopoiesis and for the initial seeding of fetal liver with definitive hematopoietic progenitor cells
Blood,
April 1, 2008;
111(7):
3313 - 3321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. Nottingham, A. Jarratt, M. Burgess, C. L. Speck, J.-F. Cheng, S. Prabhakar, E. M. Rubin, P.-S. Li, J. Sloane-Stanley, J. Kong-a-San, et al.
Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer
Blood,
December 15, 2007;
110(13):
4188 - 4197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wu, I. Maillard, M. Nakamura, W. S. Pear, and J. D. Griffin
The transcriptional coactivator Maml1 is required for Notch2-mediated marginal zone B-cell development
Blood,
November 15, 2007;
110(10):
3618 - 3623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, P. Haviernik, K. D. Bunting, and Y.-C. Yang
Cited2 is required for normal hematopoiesis in the murine fetal liver
Blood,
October 15, 2007;
110(8):
2889 - 2898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Bowie, D. G. Kent, B. Dykstra, K. D. McKnight, L. McCaffrey, P. A. Hoodless, and C. J. Eaves
Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell properties
PNAS,
April 3, 2007;
104(14):
5878 - 5882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-T. Cheng, M. Kim, M. T. Valerius, K. Surendran, K. Schuster-Gossler, A. Gossler, A. P. McMahon, and R. Kopan
Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron
Development,
February 15, 2007;
134(4):
801 - 811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Vooijs, C.-T. Ong, B. Hadland, S. Huppert, Z. Liu, J. Korving, M. van den Born, T. Stappenbeck, Y. Wu, H. Clevers, et al.
Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE
Development,
February 1, 2007;
134(3):
535 - 544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chiba
Concise Review: Notch Signaling in Stem Cell Systems
Stem Cells,
November 1, 2006;
24(11):
2437 - 2447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. K. A. Mikkola and S. H. Orkin
The journey of developing hematopoietic stem cells.
Development,
October 1, 2006;
133(19):
3733 - 3744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Breit, M. Stanulla, T. Flohr, M. Schrappe, W.-D. Ludwig, G. Tolle, M. Happich, M. U. Muckenthaler, and A. E. Kulozik
Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia
Blood,
August 15, 2006;
108(4):
1151 - 1157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-W. Lin, R. A. Nichols, J. J. Letterio, and P. D. Aplan
Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma
Blood,
March 15, 2006;
107(6):
2540 - 2543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-M. Zou, R. J. Chan, W. C. Shelley, and M. C. Yoder
Reduction of Shp-2 Expression by Small Interfering RNA Reduces Murine Embryonic Stem Cell-Derived In Vitro Hematopoietic Differentiation
Stem Cells,
March 1, 2006;
24(3):
587 - 594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Burns, D. Traver, E. Mayhall, J. L. Shepard, and L. I. Zon
Hematopoietic stem cell fate is established by the Notch-Runx pathway
Genes & Dev.,
October 1, 2005;
19(19):
2331 - 2342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Landais, R. Quantin, and E. Rassart
Radiation Leukemia Virus Common Integration at the Kis2 Locus: Simultaneous Overexpression of a Novel Noncoding RNA and of the Proximal Phf6 Gene
J. Virol.,
September 1, 2005;
79(17):
11443 - 11456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-W. Lin, R. Deveney, M. Barbara, N. N. Iscove, S. D. Nimer, C. Slape, and P. D. Aplan
OLIG2 (BHLHB1), a bHLH Transcription Factor, Contributes to Leukemogenesis in Concert with LMO1
Cancer Res.,
August 15, 2005;
65(16):
7151 - 7158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Robert-Moreno, L. Espinosa, J. L. de la Pompa, and A. Bigas
RBPj{kappa}-dependent Notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells
Development,
March 1, 2005;
132(5):
1117 - 1126.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |